Fecal microbiota transplant and re-introduction of anti-PD-1 therapy (Pembrolizumab or Nivolumab) for the treatment of metastatic colorectal cancer in anti-PD-1 non-responders. Here, PDCD1 is linked to metastatic colorectal cancer.